ARCHIVES

NiH Conference: More Discord Than Consensus At Statement’s Presentation

This article is from The Cancer Letter archive.

Vol. 23 No. 04 | January 31, 1997

Download PDF Visit The Full Archive

Related Articles

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

CMS to delay final rule publication for oncology.

October 31, 2003

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001